WHO suspends clinical test for malaria drug hydroxychloroquine

The World Health Organization (WHO) has stopped a clinical trial for hydroxychloroquine due to safety concerns after a paper published in The Lancet showed that people taking the drug were at higher risk of death and heart problems than those that were not.

During a news briefing WHO director-general, Tedros Adhanom Ghebreyesus, stated "This concern relates to the use of hydroxychloroquine and chloroquine in Covid-19,"

Co-founder of Pendect, passionate about open source and knowledge sharing. Made in Mooca.
Card reviewed by: @christoph